MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Envista Holdings Corporation Operating Cycle 2011-2026 | NVST
Annual Operating Cycle Envista Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 136 | 148 | 146 | 140 | 190 | 141 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 190 | 136 | 150 |
Quarterly Operating Cycle Envista Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 134 | 138 | - | 144 | 136 | 150 | - | 158 | 153 | 163 | - | 78.2 | 70.5 | 145 | 44.8 | 156 | 134 | 139 | 44.7 | 148 | 222 | 173 | 56.2 | 148 | 136 | 148 | 55.3 | 30.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 222 | 30.9 | 124 |
Operating Cycle of other stocks in the Medical instruments industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
313 | $ 19.92 | 0.94 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
37.1 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
184 | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
201 | $ 5.36 | -1.65 % | $ 244 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
234 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
571 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
227 | - | -0.02 % | $ 16.3 B | USA |
 |
OraSure Technologies
OSUR
|
203 | $ 2.74 | -1.79 % | $ 204 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
340 | $ 8.65 | 3.1 % | $ 174 M | USA |
 |
Alcon
ALC
|
197 | $ 80.83 | -0.37 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
266 | $ 36.3 | -1.76 % | $ 1.7 B | USA |
 |
Haemonetics Corporation
HAE
|
258 | $ 65.68 | -0.42 % | $ 3.31 B | USA |
 |
electroCore
ECOR
|
282 | $ 6.88 | -3.1 % | $ 37.9 K | USA |
 |
AngioDynamics
ANGO
|
220 | $ 10.13 | 1.5 % | $ 414 M | USA |
 |
ICU Medical
ICUI
|
178 | $ 149.56 | -0.31 % | $ 3.65 B | USA |
 |
InfuSystem Holdings
INFU
|
87.4 | $ 8.1 | 0.56 % | $ 167 M | USA |
 |
STERIS plc
STE
|
144 | $ 260.7 | -0.36 % | $ 25.7 B | USA |
 |
The Cooper Companies
COO
|
282 | $ 80.7 | 0.41 % | $ 16.1 B | USA |
 |
Masimo Corporation
MASI
|
168 | $ 134.15 | -1.54 % | $ 7.15 B | USA |
 |
Harvard Bioscience
HBIO
|
256 | $ 0.49 | -8.67 % | $ 20.8 M | USA |
 |
Glaukos Corporation
GKOS
|
237 | $ 117.26 | -1.52 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
206 | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
71.3 | $ 148.9 | -0.06 % | $ 4.65 B | USA |
 |
LeMaitre Vascular
LMAT
|
43.2 | $ 84.46 | 0.72 % | $ 1.9 B | USA |
 |
Intuitive Surgical
ISRG
|
233 | $ 503.83 | -0.73 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
435 | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
298 | $ 60.61 | -1.69 % | $ 220 M | USA |
 |
Microbot Medical
MBOT
|
180 | $ 1.82 | -2.15 % | $ 18.6 M |  Israel |
 |
Nephros
NEPH
|
212 | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Milestone Scientific
MLSS
|
545 | $ 0.3 | -1.38 % | $ 23.9 M | USA |
 |
Pro-Dex
PDEX
|
228 | $ 37.95 | -3.69 % | $ 125 M | USA |
 |
Predictive Oncology
POAI
|
306 | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
105 | $ 13.88 | 1.91 % | $ 667 M | USA |
 |
Becton, Dickinson and Company
BDX
|
169 | $ 201.3 | 0.11 % | $ 57.9 B | USA |
 |
Repligen Corporation
RGEN
|
297 | $ 152.02 | -2.78 % | $ 8.47 M | USA |
 |
ResMed
RMD
|
202 | $ 250.46 | -2.78 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
37.9 | $ 21.94 | -2.85 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
311 | $ 2.24 | -3.86 % | $ 181 M | USA |
 |
Retractable Technologies
RVP
|
299 | $ 0.69 | -2.01 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
100 | $ 18.74 | -1.06 % | $ 921 M | USA |
 |
Teleflex Incorporated
TFX
|
221 | $ 105.09 | -0.37 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
145 | $ 225.53 | -3.06 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
118 | $ 12.32 | 0.37 % | $ 2.5 B | USA |